KTRA

Kintara Therapeutics Inc
6.99
0.00 (0.00%)

Kintara Therapeutics Inc. (KTRA) Fundamentals

Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The Company operates within a single operating segment the research and development of cancer indications, and operates primarily in one geographic area, being North America.
SHARE INFORMATION
Market Cap$ 11,296,861
Shares Outstanding1,616,146
Float1,607,942
Percent Float99.49%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -27.50
Latest Fiscal Date2022-06-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment CashStock
HOLDERS
Institutions19
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months478,600
Institutional Holdings Percent4.5%
Institutional Sold Previous 3 Months890,372
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months4,481,820
Insider Holdings Percent3.5
Insider Sold Previous 3 Months-
Insider Shares Owned2,794,121
TRADING INFO
52 Week High$ 42.00
52 Week Low$ 3.50
52 Week High Change$ -68.58
21 Day Moving Average$ 6.9321
21 Day Extended Moving Average$ 6.8477
50 Day Moving Average$ 7.5479
50 Day Extended Moving Average$ 7.07
200 Day Moving Average$ 8.5259
200 Day Extended Moving Average$ 11.826
10 Day Average Volume30,481
20 Day Average Volume35,759
30 Day Average Volume42,831
50 Day Average Volume464,832
Alpha-0.040636
Beta1.0068
Standard Deviation0.286269
R20.036088
7 Day Price Change$ 0.09
7 Day Percent Change1.3%
21 Day Price Change$ -0.31
21 Day Percent Change-4.25%
30 Day Price Change$ 0.10
30 Day Percent Change1.45%
Month to Date Price Change$ 0.69
Month to Date Percent Change10.95%
Quarter to Date Price Change$ 0.10
Quarter to Date Percent Change1.45%
180 Day Price Change$ -1.87
180 Day Percent Change-21.11%
200 Day Price Change$ -5.31
200 Day Percent Change-43.15%
Year to Date Price Change$ 0.10
Year to Date Percent Change1.45%

Kintara Therapeutics Inc. (KTRA) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-3.60
Total Debt To Equity0.00
Int Coverage-9,337.40
Current Ratio2.30
Leverage Ratio-7.90
Quick Ratio2.00
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.40
Enterprise Value$ 15,112,917
Price to Sales0.00
Price to Free Cash-0.60
PE High Last 5 Years-0.80
Price To Book7.80
Price To Cash Flow0.00
PE Low Last 5 Years-0.90
Price to Tangible Book-3.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-121.85
Return on Equity-1,697.57
Return on Capital-1,697.57

Kintara Therapeutics Inc. (KTRA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMarcum LLP
CEORobert E. Hoffman
Emplyoees3
Last AuditUE
CIK0001498382
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address9920 Pacific Heights Blvd
Suite 150
San Diego, CA 92121
Websitehttps://www.kintara.com
Facsimile-
Telephone+1 858 350-4364
Emailir@delmarpharma.com


Your Recent History
NASDAQ
KTRA
Kintara Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.